ELECTIONS

UICC General Assembly Renaissance Hotel

Washington DC

7 July 2006

Index

President-Elect ........................................................................... 1

Dr David Hill (Australia) ............................................................................ 2

Board of Directors ...................................................................... 3 Dr Farhat Ben Ayed (Tunisia) ..................................................................... 4

Dr Eduardo Cazap (Argentina) ................................................................... 5

Dr Mary Gospodarowicz (Canada) ............................................................... 6

Dr Xishan Hao (China) .............................................................................. 7

Ms Ranjit Kaur (Malaysia) .......................................................................... 8

Dr Tomoyuki Kitagawa (Japan) .................................................................. 9

Dr Arun Kurkure (India) .......................................................................... 10

Dr Melissa Luwia (Indonesia) ................................................................... 11

Dr Alex Markham (UK)............................................................................. 12

Mr Fred Mickelson (USA) ......................................................................... 13

Ms Pearl Moore (USA) ............................................................................. 14

Dr Harri Vertio (Finland) .......................................................................... 15

Dr Roberto Zanetti (Italy) ........................................................................ 16

Dr Witold Zatonski (Poland) ..................................................................... 17

Nominating Committee .............................................................. 18 Dr Louis J Denis (Belgium) ...................................................................... 19

Ms Elisabeth Hjorth (Denmark) ................................................................ 20

Dr Ignacio Musé Sevrini (Uruguay) ........................................................... 21

Dr Eliezer Robinson (Israel) ..................................................................... 22

1

President-Elect

CRITERIA FOR NOMINATION Understanding UICC

• must understand the scope, work and mission of UICC • must have a vision beyond national boundaries and an understanding of the key global

challenges and issues • must be able to contribute to understanding of issues in middle- and low-income (developing)

countries Commitment

• must have the support of their organisation/Board • must be able to attend at least two face-to-face meetings per year • must maintain contact with national societies in the region and agree to help recruit new UICC

members Decision-Making

• must be willing and able to contribute positively to the decision-making process of the Union Ethical Standards

• must have a reputation for integrity, honesty and adherence to high ethical standards Teamwork

• must have demonstrated ability to act within a team setting and to motivate others Cultural Sensitivity

• must be culturally sensitive Fluent in English PERSONAL EXPERIENCE AND CAPABILITIES

• is a proven leader with a global vision • has demonstrated capacity as a team builder • is highly regarded among peers • has a record of distinguished achievement and/or exceptional future promise in fields that are

relevant to UICC with past/current national and international activities in the cancer field • is familiar with UICC and has served and represented its best interests • demonstrates ability and willingness to engage in the strategic work of UICC • has expressed ability to commit time for the position • has demonstrated ability to play a substantive role vis-à-vis policymakers and other political

actors; to give cancer a higher priority on their agenda • is well connected to cancer networks/institutions, governmental and non-governmental

organisations, the academic community, etc. that will benefit the work and impact of UICC’s activities

• has access to resources and demonstrates willingness to open doors and raise funds for UICC • has experience in organising major international cancer conferences • benefits from a supportive infrastructure, preferably within a member organisation • has expressed readiness and strong interest to be President

VOTING PROCEDURE

• The Nominating Committee will propose Dr David Hill • Voting Delegates will vote by show of voting cards:

Green = Yes Red= No White = Abstention Simple majority decision

2

President-Elect

Current Positions

• 2002-to date CEO of The Cancer Council Victoria • Deputy Chair National Health Medical Research Council Research

Committee (national policymaking role). Involved in pioneering work to enable linkages and appropriate reward systems to ensure, through policy change, that research knowledge is transformed more quickly into prevention and clinical practice

• Is on the faculty (Honorary) at the University of Melbourne, Monash University and Deakin University

Recent Positions

• 1986 -1992 Founding Director of the Centre for Behavioural Research in Cancer.

• 1966–1986 Director Education, Cancer Council Victoria • 1988-2004 Chaired Australian National Expert Advisory

Committee on Tobacco which advised the Council of Dr David Hill, Australia Federal and State Cabinet Ministers on National Drug Policy • Member of ministerial task force on cancer, state of Victoria, Australia (responsible for advising on

implementation of governments cancer services framework • Participated in national collaborative research studies on breast cancer treatment, tobacco use, and

policy. Extensive research track record with emphasis on tobacco, solar screening, cancer screening Academic Titles: MA and PhD Psychology, Melbourne University Published Scientific Articles include papers on the prevalence of adolescent and adult smoking

• strategies for smoking cessation, reduction of smoking uptake, smoking regulation, behavioural aspects

• of screening mammography, monitoring trends in skin cancer prevention and exploring determinants of

• behaviours related to skin cancer prevention • Co-editor of Prevention of Skin Cancer by Kluwer Academic Publishers 2004. Awards • 2001 Awarded Australian National Honour in the Order of Australia (AM) for services to the promotion

of community health, particularly in the development of cancer awareness and prevention programme.

• 1991 Ian Mathew Campbell prize in Clinical Psychology (outstanding contribution to scientific or professional status of clinical psychology in Australia)

Selected UICC Positions Dr Hill was the visionary initiator of UICC’s World Conference for Cancer Organisations. He organised, hosted and identified funding for the first World Conference in 1996 (there have been three conferences since in Atlanta, Brighton and Dublin) • 1976-1996 Member of UICC COPES programme committee • 1976 -1990 Chair UICC project Doctor Involvement in Public Education about Cancer which

organised training workshops throughout the world. Published accompanying UICC guidelines. • 1990-1994 Chair UICC project Behavioural Science Applications. Organised workshops in several

countries. Published accompanying UICC guidelines. • Member of the UICC World Cancer Congress 2006 track planning committee • Host APCASOT Fellows • Plenary speaker at the UICC Congresses Experience relating to UICC Strategic Directions

• Received prestigious grants for research in prevention, early detection and tobacco control • Has had administrative responsibility for delivery population-wide programmes in relation to

these areas. • Has participated in national and international committees in cancer prevention

3

Board of Directors

CRITERIA FOR NOMINATION Understanding UICC

• must understand the scope, work and mission of UICC • must have a vision beyond national boundaries and an understanding of the key global

challenges and issues • must be able to contribute to understanding of issues in middle- and low-income (developing)

countries. Commitment

• must have the support of their organisation/Board • must be able to attend at least two face-to-face meetings per year • must be able to maintain contact with national societies in the region and agree to help recruit

new UICC members. Decision-Making

• must be willing and able to contribute positively to the decision-making process of the Union. Ethical Standards

• must have a reputation for integrity, honesty and adherence to high ethical standards. Teamwork

• must have demonstrated ability to act within a team setting and to motivate others. Cultural Sensitivity

• must be culturally sensitive. Fluent in English PERSONAL EXPERIENCE AND CAPABILITIES

• has board/committee experience at international, regional or national levels • is able to bring to the Board regional and/or strategic experience (UICC Strategic Directions) • can strengthen the Board’s understanding of specific issues of relevance (e.g. cancer, education,

e-health, marketing, legal issues etc.) • is currently professionally active • is locally connected to relevant experts and networks.

with skills and, expertise in any of the following areas

• cancer practice • supportive care • public health, cancer control planning, policy development • cancer education, training, advocacy and campaigning • communications, strategy, media relations, e-health • knowledge transfer • finance, such as accountancy, strategy, financial planning or management • fundraising, such as corporate and foundation fundraising – willing to open doors to sponsors and

donors • legal skills • membership services, support, recruitment • partnership building • Access to resources:

• where possible, travel costs to be covered by their organisation • in exceptional circumstances, UICC will contribute to these costs in order to encourage

participation from resource-constrained countries. VOTING PROCEDURE

NOTE: For continuity, terms on the Board will normally be staggered so that not all members rotate off at the same time. At subsequent General Assemblies, therefore, the Nominating Committee will present a slate of seven nominees for the election of five Board Members. However, to allow for the transition in 2006 to the new two-year interval between General Assemblies,

the Nominating Committee will present a slate of 14 nominees • on the ballot sheet, Voting Delegates will select 10 preferred nominees • the 10 nominees, who received the largest number of votes, are elected by simple majority • the General Assembly will be asked for authorization to defer to the Board the decision of which

five of the newly elected Board members will serve for two or four years. • in addition, the Board will elect a further four members, two of whom shall serve for a two-year

term and two shall serve for a four-year term.

4

Board of Directors

Current Positions • President: Latin American-Caribbean Society of Medical Oncology

(SLACOM), 2004 • Chairman, International Affairs Committee. American Society of

Clinical Oncology, 2006-2007 • South America Representative Developing Countries Task Force.

European Society of Medical Oncology (ESMO), 2004 • Member: Cancer Technical Group, Programme on Cancer Control,

WHO, 2004

Dr Eduardo Cazap, Argentina Recent Positions • Professor of Clinical Oncology, Universidad del Salvador, 1984-98 • Professor of Medical Oncology I, Universidad Católica Argentina,1988-2000 • President: Argentine Association of Medical Oncology, 1996-98 • President: Argentine Association of Medical Oncology, 2000-2002 • Director, Instituto Dr. Estévez, Buenos Aires, 1985-2002 • Regional Representative: Representing Latin America, European Society of Medical • Oncology (ESMO), 1996-2004 Training and Education • MD, University of Buenos Aires, 1972 • Resident in Internal Medicine, Hospital Durand, Buenos Aires, 1973-75 • Specialist in Medical Oncology, Universidad Del Salvador, 1978 • Fellowship, Pan American Health Organization, Lombardi Cancer Center, Georgetown University, 1984 • Principal Investigator, Collaborative Cancer Research Treatment Programme (CCTRP) PAHO/NCI, 1984 • American Cancer Society Fellowship, 1985 • European Rectification in Medical Oncology, ESMO, Copenhagen, 1991 Selected UICC Positions • Member: 2006 UICC World Congress Programme Planning Executive Committee, • UICC Professional education workshops and basic and advanced courses on oncology were carried

out in several Latin American countries.

5

Board of Directors

Dr Farhat Ben Ayed, Tunisia Current Position President: Association Tunisienne de Lutte contre le Cancer (Tunisian Association Against Cancer) Recent Positions • 1981-2005 Head of Medical Oncology of Institute Salah Azaiz, Tunis • 1979-1981 Assistant Professor of Medicine, Institute Gustave Roussy • 2000 Founder, Tunisian Association of Palliative Care • 1999-2004 Technical Director, Tunisian/Italian Coordination Project • 1995-2004 Expert, EMROWHO Regional Office • 1992 Co-founder, Tunisian Association for Health Promotion • 1987 Founder of Tunisian Association Against Cancer Society Memberships • ASCO, European Society of Mastology • Tunisian Society of Medical Science • European Association of Palliative Care and President, Tunisian Chapter IASP • Training European School of Cancerology, Scientific Committee (EFEC) • International Society of Geriatric Oncology • ESO Challenge Group Scientific Committee • French-Speaking Society of Medical Ethics (SFFEM) Publications • Several published abstracts and major publications (see CV) Training and education • MD, University of Medicine, Montpellier, France Selected UICC Service • Prevention and Early Detection Task Force Particular Attributes • Tunisia is an emerging country whose development status enables the setting of a programme fight

against cancer than can be used as a model and platform for other African countries. Tunisia maintains special connections with Nigeria, Morocco, Algeria, Libya and other French speaking countries in Africa.

• Dr Ben Ayed can be useful as a relay and reference for all these countries as an oncologist and founder of a cancer-fighting association.

6

Board of Directors

Current Positions • Medical Director, Princess Margaret Hospital, University

Health Network, Toronto, Canada • Regional Vice-President, Cancer Care Ontario, Canada • Professor and Chair of Dept of Radiation Oncology, University

of Toronto, Canada Recent Positions • Canadian Association of Radiation Oncology: President • Canadian Prostate Cancer Research Initiative – Management

Committee • National Cancer Institute of Canada: Canadian Committee

on Cancer Staging – Chair, • National Cancer Institute of Canada: National Forum

on Prostate Cancer • National Cancer Institute of Canada: Clinical Trials Group

Dr Mary Gospodarowicz, Canada

Recent Positions (contd) • Chair GU Committee • American Society of Therapeutic Radiology and Oncology: Scientific Programme Committee • NCI-US Programme Review Groups and Panels, NCI SubCommiittee H – Clinical Trial Groups • ASCO, International Affairs Committee • NCI-US Programme review groups and panels Education and Training • 1971 MD, University of Toronto • 1975 Fellow, Royal College of Physicians Internal Medicine • 1977 Fellow, Royal College of Physicians Radiation Oncology Specialty Certification, American Board of Medical Oncology Publications • Over 200 publications Selected UICC Positions • UICC Council • UICC Executive Committee • UICC TNM Prognostic Factors Core Group and Task Forces • Chief Editor, Prognostic Factors in Cancer (1995) (2001) (2006) • UICC Membership and Governance Task Force • UICC/WHO/ICUD Consultation on Bladder Cancer; Prostate Cancer NGO Experience and UICC Service Mary has a long track record of service in NGOs. She is a past President of the Canadian Association of Radiation Oncologists. She has served on various provincial, national and international committees. A member of the American Society of Clinical Oncology International Affairs Committee, she is the UICC liaison to the Commission on Cancer of the American College of Surgeons. In 1996, she was a co-chair of the NCI–CCS National Forum on Prostate Cancer. She was also involved in the activities supporting patient groups including Man to Man and US TOO. She is a member of the scientific advisory boards of the Lymphoma Research Foundation and Lymphoma Foundation of Canada. She serves on the UICC TNM Project Committees. Currently, she chairs the UICC Task Forces on Prognostic Factors. In the past 10 years she has co-edited three books on Prognostic Factors in Cancer, the newest being published for the 2006 UICC World Cancer Congress. Her service to UICC involved the Council and the Executive Committee. She initiated programmes through the UICC to actively promote e-initiatives to raise the standard of cancer care worldwide. Particular Attributes Mary Gospodarowicz, Professor and Chair of the Department of Radiation Oncology at the University of Toronto is currently the Director for Oncology at the Princess Margaret Hospital University Health Network, the largest cancer centre in Canada. She has specialty certifications in internal medicine, medical oncology and radiation oncology. Her expertise and research focuses on lymphomas and genitourinary cancers. She is currently actively involved in survivorship research and programmes.

Board of Directors

Current Positions

President, Tianjin Medical University Director, Tianjin Medical University Cancer Hospital Director, Tianjin Cancer Research Institute Full Professor of Oncology, Tianjin Medical University Vice-President, Chinese Medical Association President, Chinese Society of Oncology Executive President, Chinese Anti-Cancer Association Editor-in-Chief, Chinese Journal of Clinical Oncology Executive Council Member, Asian and Pacific Federation

of Organization for Research and Control (APFOCC)

Dr Xishan Hao, China Recent Positions

Chairman/Honorary Chairman, Asian Breast Cancer Association Editor, Journal of Supportive Care in Cancer

Selected Honours and Awards

Academician, Chinese Academy of Engineering Outstanding Achievements in Oncology, awarded by the Ministry of Public Health of China Second Prize in the National Technology Progress Award, awarded by the Ministry of Science and

Technology Visiting Professor at Showa University and Kurume University, Japan

Training and Education

1970, MD, Tianjin Medical University, China 1974, Fellow in Oncology, Tianjin Medical University Cancer Hospital, China 1984, Visiting Scientist, Immunology Research Division, Centocor Inc, Pennsylvania, USA 1986, Visiting Scientist, Memorial Sloan-Kettering Cancer Center, USA 2005, Management Training in Executive Education Programmes, Columbia University Graduate

School of Business, USA Publications

Published six textbooks and 140 publications in Chinese and international medical journals Selected UICC Positions: None Particular Attributes

Dr Hao is a leading surgical oncologist and medical educator, and an active member in the NGOs that support medical research in China. During his 36 years in practice, he has earned numerous accolades and awards in China, as well as internationally, for his innovative approach in surgery and his contribution to the advancement of public health and medical education. He specializes in gastric cancer and pioneered the surgical model in reconstructions after total gastrectomy. He is currently spearheading the stem cell research effort in transplantation for solid tumour. Due to his great contribution, he was elected an academician of the Chinese Academy of Engineering, the highest honour in the field of engineering and technological sciences in China.

Dr Hao is a good speaker and communicator internationally. He has been a keynote speaker in many international conferences. As the President of Tianjin Medical University for over 10 years, he has established much collaboration with famous universities and cancer centres globally.

Dr Hao can speak very good English. His talent in communication will be immense service to this new governing body.

Dr Hao has a good reputation in oncology worldwide. He is a Fellow of the American College of Surgeons (FACS), and a member of the American Association of Cancer Research (AACR) and the WHO International Agency for Cancer Registry (IACR).

7

8

Board of Directors

Current Affiliation • Manager, Public Affairs Projects, Tanjong Management

Services – Corporate Company Current Status • Breast cancer survivor since 1998 Current Voluntary Positions • President, Reach to Recovery International, UICC • President, Breast Cancer Welfare Association, Malaysia

(Reach to Recovery Programme) • President, Malaysian Breast Cancer Council • Committee member, Cancer Control in Low- and Middle-

Income Countries, Institute of Medicine of the National Academies in Washington

• Member, Board of Directors, International Association for Community Development (IACD)

Ms Ranjit Kaur, Malaysia

Education and Training • 1974-1978: BSc, University of Rajasthan, India • 1979-1981: Diploma in Physiotherapy, S.M.S. Medical College, Jaipur, India • 1995- 1996: MSc in Community Disability Studies in Developing Countries, University College

London, UK Publications • Presented 35 papers • One of the recent is a paper by Ranjit entitled Cancer – My Personal Account published in The Lancet,

Issue no. 9472, May 14th 2005, Vol 365, Page 1742. Selected UICC Position(s) • President, Reach to Recovery International (2003 to present) • Editor in Chief, Bloom (RRI magazine) • Co-track Chairperson, 2006 UICC World Cancer Congress • UICC Patient Forum think-tank • RRI Conference Organising Committee (Malaysia, Greece, India, Sweden) • She was conferred the 2004 Outstanding UICC Volunteer Award at the UICC World Conference for

Cancer Organisations in Dublin in November 2004.

9

Board of Directors

Current Positions • 1999 to present, President or Principal Member, Japanese

Society of Cancer Molecular Epidemiology • to present, Council member of several cancer-associated

funds and organisations

Recent Positions • 1978 Member and Chief of Dept of Pathology, the

Cancer Institute of the Japanese Foundation for Cancer Research (JFCR)

• 1985 Vice-Director, the Cancer Institute of JFCR • 1993–2006 Director, the Cancer Institute of JFCR • 2002 President, Japanese Cancer Association • 2006 Director Emeritus, the Cancer Institute of JFCR

Dr Tomoyuki Kitagawa, Japan

Selected Honours and Awards • ACS-Eleanor Roosevelt International Fellowship for Cancer Research of UICC • Nagayo Prize of the Japanese Cancer Association

Education and Training • 1963 MD, University of Tokyo School of Medicine • 1968 PhD, Postgraduate Course of University of Tokyo • Specialised professional field: human pathology, oncology, experimental hepatocarcinogenesis

Publications • 170 publications

Selected UICC Positions • 1982-1985 Fellowship Committee of UICC • 1995-2000 Chair of Special Project for Molecular Epidemiology • 2002 to present Member of Council and Nominating Committee • Member of Executive Programme Committee for the UICC World Cancer Congress • Chair of Japan National Committee for UICC since 2003 Particular Attributes • Balanced judgment on UICC activities • Organisation of international conferences

10

Board of Directors

Current Positions • Breast Cancer Surgeon and Gynaecological Oncologist • Honorary Secretary, Indian Cancer Society

Recent Positions • Indian Cancer Society: Honorary Secretary, Managing Trustee

(CEO) • Mumbai Cancer Registry: Principal Investigator • Indian Co-operative Oncology Network (Clinical Research),

Executive Committee Member • Associate Editor – Indian Journal of Cancer • Indian Cancer Society and Indian Society of Oncology

Dr Arun Kurkure, India

Recent Positions (contd) • Indian Cancer Society and Indian Co-operative Oncology Network • Member of Task Force for Formulation of Strategy for Cancer Control • Invited for formulating policy for CME and Accreditation for Oncologists • Advisory Committee Member of ACSU Chennai Awards • Bronze Medal in Obstetrics and Gynaecology Education and Training • Master of Surgery Oncology • Certificate Course in Hospital Management Selected UICC Positions • Executive Committee • Knowledge Transfer Steering Group • Cancer Control Planning Task Force • Promoting Evidence-Based Interventions Task Force • Member of the 2006 UICC World Cancer Congress Programme Executive Committee • e-UICC Think-Tank • Advisory Board Member of Asian Pacific Journal of Cancer Prevention • Dr Kurkure has brought in the Hub and Spoke model - “Think Globally and Act Locally ” - to UICC’s

future new activities. Particular Attributes • Dr Kurkure has had a significant impact on cancer control in India and throughout the world. He has

contributed greatly to the mission of the UICC as an Executive Committee member and through his involvement with the 2006 UICC World Cancer Congress Programme Executive Committee. He has also been involved with the American Cancer Society University, the Society’s training programme to build capacity and share best practices among international cancer societies.

• In India, Dr Kurkure has demonstrated superb leadership as managing trustee of the Indian Cancer Society. He is a principal investigator with the Mumbai Cancer Registry, an executive committee member of the Indian Co-operative Oncology Network, and the associate editor of the Indian Journal of Cancer. He has helped shape India’s cancer policies through his involvement with the Task Force for formulation of Strategy for Cancer Control and oncologist accreditation. Dr Kurkure has received a Bronze Medal in obstetrics and gynaecology.

• Dr Arun Kurkure can bring to the Board skills related to governance, cancer control strategy, rehabilitation and a support system for cancer patients. He is a practising Breast Cancer Surgeon and Gynaecological Oncologist.

• Dr Kurkure was invited to join the Scientific Advisory Committee of the Breast Health Global Initiative and also contributed to the BHGI 2005 Guidelines for International Breast Health and Cancer Control- Treatment and Resource Allocation.

11

Board of Directors

Current Positions • Since April 2006, Second Chairman of the Indonesian Cancer

Foundation, Social Services (in charge of early cancer detection, hospice home care, Reach to Recovery, Indonesian Ostomy Association, financial aid for cancer treatment for underprivileged cancer patients)

• 1996-2006, Chairman, Service and Rehabilitation Department of the Indonesian Cancer Foundation

• 1992-1996, Vice-Chairman, Service and Rehabilitation Department of the Indonesian Cancer Foundation

• 1990-present, Executive Director, Early Detection Center, Indonesian Cancer Foundation

Dr Melissa Luwia, Indonesia

Current Positions (contd) • 1982-present, Medical Coordinator Sasana Marsudi Husada, hostel for cancer patients and Pap smear

clinic • Since 1992, Board Member, Indonesian Cancer Foundation • Member, Indonesian Oncology Association

Education and Training • MD, Faculty of Medicine, Triakti University, Jakarta (1980) • Master of Hospital Administration, IEU Institute of Management, Jakarta (1991) Selected UICC Positions • UICC Council, 1992 to present • Speaker at several UICC conferences • Track 4 team member, 2006 UICC World Cancer Congress Particular Attributes • Melissa Luwia has been working as an employee for the Indonesian Cancer Foundation (ICF) as a

doctor at a Pap smear and consultation clinic run by the ICF since it was established in 1982. • She was at the planning stage of the clinic and was the only doctor operating the clinic until 1985. As

the clinic is growing and has to serve more patients, other doctors are being recruited. • In 1990, the clinic was upgraded to an Early Detection Centre for cancer with more facilities for

breast cancer and other types of cancer. Melissa was appointed as director and has the responsibility to manage the clinic with four full-time doctors, 8-10 specialists and 40 other staff.

• In 1992, she was elected as a board member with the position of Vice-Chairman of the Services and Rehabilitation Department. She was then assigned as Chairman of the Services and Rehabilitation Department for the next term, from 1996 until April 2006.

• In April 2006, she was elected as Second Chairman, Indonesian Cancer Foundation (in Social Services). Besides early detection, she is responsible for patient-support programmes, especially for underprivileged cancer patients. After attending several international conferences, she set up a Hospice Home Care programme in 1996.

• Reach to Recovery Indonesia was also set up in 1997 adapted from the UICC programme Reach to Recovery International, with the assistance of Dr Jeff Dunn.

• Indonesian Ostomy Association was set up in 2000 with the support of Asian Ostomy Association.

12

Board of Directors

Current Positions • Since 2003: Chief Executive Officer of Cancer Research UK • Professor of Medicine at the University of Leeds • Director of the Molecular Medicine Unit at St James University

Hospital • Has over 20 years Pharmaceutical and Diagnostic experience in

UK and USA (GD Searle, Astra Zeneca)

Recent Positions • Chairmanship and Membership of a number of influential

committees of the Medical Research Council, Department of Health, Department of Trade and Industry and Welcome Trust

Dr Alex Markham, UK Education and Training • 1974: PhD, Chemistry, University of Birmingham • Postdoctoral Award, Japan and London • Clinically qualified, having trained at London and Oxford with accreditation of Pathology and Internal

Medicine Selection of Honours and Awards • 1990: Queens Award for Technological Achievement • Fellow, Academy of Medical Sciences • Chairman, National Cancer Research Institute, UK Publications • Author of several publications UICC Service: None Particular Attributes • Professor Markham has a distinguished reputation in medical science and has proven leadership will

be of immense service to this new governing body. He is an experienced leader and would be committed to serving UICC’s mission with his time and considerable talent as a board member.

• Professor Markham has made far-reaching contributions to medical science in various fields. In 2003, he was appointed chief executive of Cancer Research UK. Although he possesses a doctoral degree in chemistry, Markham is also trained in pathology and internal medicine. He is Professor of Medicine at the University of Leeds and director of the Molecular Medicine Unit at St James University Hospital. Professor Markham has lent his expertise and leadership to several national committees in Britain, including the Medical Research Council, the Department of Health, the Department of Trade and Industry, and the Wellcome Trust. He was recently appointed to a fellowship of the Academy of Medical Sciences and is the current chair of the National Cancer Research Institute in the UK.

• The research training of clinical academics has been a longstanding interest of Professor Markham’s. He is also involved in the regulatory processes for new medicines in the UK through his involvement with the British government’s Gene Therapy Advisory Committee and the Committee on Safety of Medicines. In addition, he has a broad scope of commercial experience, including board responsibilities for the worldwide development of fingerprinting for forensic and medico-legal applications. His involvement earned him the Queen’s Award for Technological Achievement in 1990

13

Board of Directors

Current Position • Corral Creek Consultants, Inc

Recent Positions • 2004 Cancer Control speaker, trainer and group facilitator • 2001 National Chair of ACS • 30 years as a senior Executive of a Fortune 500 corporation • Help secured the passage of the Tobacco Tax Proposition 99 in

California

Mr Fred Mickelson, USA Education and Training • BS in Economics and Administrative Science Selected UICC Position • 2002-2006 Member of Council Particular Attributes • His outstanding leadership and invaluable experience will be of immense service to this new

governing body. Mr Mickelson is a well-regarded leader in the international health community and would be committed to serving UICC’s mission with his time and considerable talent as a board member.

• As a current member of the UICC’s volunteer leadership, Mr Mickelson is playing an integral role in helping to further its global mission and expand its lifesaving reach. He has also demonstrated a commitment to volunteer leadership that has resulted in several cancer NGO board appointments, including serving as National Chair of the Board of the American Cancer Society in 2001.

14

Board of Directors

Current Positions • Founding Member and CEO, ONS, ONS Foundation, Oncology

Nursing Certification Corporation and ONSEdge (previously known as Oncology Education Services, Inc.)

• Adjunct Assistant Professor in School of Nursing at University of Pittsburgh

Recent Positions • Past treasurer in the American Academy of Nursing • Friends of Cancer Research Board • Nursing Economics Foundation Board • Editorial Board of European Journal of Cancer Care • Member of C-Change

Ms Pearl Moore, USA Recent Positions contd • Advisory Board of Johnson & Johnson Campaign for Nursing’s future • School Nursing Board of Visitors, University of Pittsburgh Selection of Honours and Awards • Fellow, American Academy of Nursing • Recipient, Association of Community Cancer Center Achievement Award • Distinguished Merit Award International Society of Nursing and Cancer Care • ONS Distinguished Service Award • Carlow College Women of Spirit Award • Legacy Laureate University of Pittsburgh • ACS Distinguished Service Award • ONS Lifetime Achievement Award Education and Training • RN • MN • FAAN Publications • Multiple publications and research papers on cancer nursing Selected UICC Positions • 1990-2000: UICC Nursing Chair • Delivered UICC courses in 20 countries • Organised Nursing sessions at UICC Congresses • Initiated International Oncology Nursing Fellowships • Participated in several inter-disciplinary programmes, including a programme on pain management in

Israel, a Cancer Management conference in Antwerp, and the Psychosocial Aspects of Breast Cancer conferences in Lucerne and Helsinki

• Chaired the IONF Fellowship scheme • Member of the 2006 WCC Programme Planning Committee Particular Attributes Pearl Moore was a UICC Nursing Project Committee member for 13 years (1987-2000) and chairperson for 10 years (1990-2000). Under her leadership the Nursing Education Project expanded its scope and impact by • Delivering Cancer Nursing Courses worldwide in 20 countries • Expanding the UICC Congress Nursing presentations to include oral abstract sessions, invited lectures

and poster sessions • Initiating the International Oncology Nursing Fellowship (IONF) programme in 1992 • Participating in two World Conferences on Tobacco OR Health

15

Board of Directors

Current Position • Secretary General, Cancer Society of Finland since 2003 National Activities • 1972-1973 University Hospital of Helsinki • 1974 The Health Centre of Espoo • 1975-19781 The Headquarters of the Finnish Defence Forces • 1979-1989 The National Board of Health

• 1989-1996 The Cancer Society of Finland (Senior Medical Adviser)

• 1996-2003 Finnish Centre for Health Promotion (Director) • 1984-1989 WHO, Euro, and WHO, HQ, Temporary adviser, short

periods • 1985-1992 Coordinator of the WHO Healthy City project in

Finland • 1991-1994 European coordinator, UICC COPES programme

• 1995-2003 European Union Cancer Experts Group

Dr Harri Vertio, Finland

National Activities (contd) • 2003-2005 Coordinator, Nordic Cancer Union • 1989-1995 Medical Editor, Syöpä-Cancer publication • 1991-1992 Editorial Board, International Journal of Health Promotion • 1991-1995 Editorial Board, Finnish Medical Journal International Activities • Chair, Organising Committee of the 4th European IUHPE Conference on Effectiveness and Quality of

Health Promotion, Helsinki and Tallinn, 1999 • Co-chair, 12th World Conference on Tobacco OR Health Organising Committee, Helsinki, 2003 • Chair, Programme Committee of the 12th World Conference on Tobacco OR Health, Helsinki, 2003 Publications • Eight books and more than 50 scientific articles Education and Training • MD, University of Helsinki, 1972 • PhD, University of Tampere, Dissertation on Health behaviour of conscripts in Finland, 1984 • Specialist in Health Care, 1986 • Postgraduate course on community planning. The Polytechnical Institute, Helsinki 1985–1986 Selected UICC Positions • Organising Committee of the Smokefree Europe conference on tobacco or health, Helsinki, 1996 • UICC COPES committee, 1990-1994 • Cancer Society of Finland received the award for Outstanding UICC Member Organisation in 2004 Particular Attributes • Dr Vertio is an excellent and well-liked speaker. • As a strong supporter of high-quality evidence-based cancer research and medicine as basis for all

cancer control work, Dr Vertio also has analytical views on alternative care in cancer. He has thrown light on the topic through a medical review.

• In addition to a significant position and influence in national cancer control, Vertio has a deep understanding of the global challenges and perspectives of cancer control. His commitment to support middle- and low-income countries is seen e.g. in the financial contribution of the Cancer Society of Finland for the UICC ICRETT Foundation as well as the cancer registry of Trivandrum in India.

• As a member of the UICC Board, Dr Vertio would represent the knowledge and skills of the Nordic cancer community and be willing to share relevant competence in the Nordic area with the global community. He would maintain close contacts with the Nordic cancer organisations as well as other European organisations through membership of the Nordic Cancer Union (NCU) and the Association of European Cancer Leagues (ECL).

• Harri Vertio has expressed his willingness to serve as a UICC Board member for a two- or four-year period and to contribute to the work and development of the organisation to his best expertise. He is committed and available to attend the meetings and other communications of the Board and any other committees that he would be appointed to. Dr Vertio has the support of the Board of the Cancer Society of Finland to overtake this position.

• Harri Vertio easily fulfils the criteria of having reputation for integrity, honesty and adherence to high ethical standards as well as excellent ability to act within a team setting. He is highly regarded among his peers.

16

Board of Directors

Current Positions • Health, Rome Since 1985, Professor of Epidemiology, National

Institute of • Since 1989, Director of the Piedmont Cancer Registry, CPO,

Turin • Since 1990, Member Board of Oncology, Turin • Since 1992, General Secretary, South European Cancer

Registries Association • Since 1992, Principal Investigator Helios Project • Since 1992, Chief Editor, Cancer in Italy

Dr Roberto Zanetti, Italy Recent Positions • Since 1998 General Secretary, Italian Association of Cancer Registries • Since 2002 European Representative, Board, IACR • Since 2004 Visiting Professor, Geneva University • Since 2004 President, Scientific Advisory Board, Epidaure, Montpellier • Since 2004 Professor, Master in Epidemiology, Turin • Researcher in Cancer Epidemiology Publications • 67 articles on indexed journals, 8 books • MD Medicine, University of Turin (78) • PhD Biostatistics, University of Milan (84) • PhD, Epidemiology, University of Turin UICC Service: None Particular Attributes • Dr Zanetti is a highly qualified researcher in Cancer Epidemiology. His major contributions are in the

field of measuring the cancer impact (Cancer Registration), in the aetiology of melanoma, and in screening programmes evaluation.

• Dr Zanetti has a long experience as leader of scientific associations and cooperation bodies, both at Italian and at international level. He has been the Executive Secretary of the South European Association of Cancer Registries. From this position he has actively promoted cooperation for scientific interchange and training with many countries in Central and Southern America and Northern Africa.

• To a strong scientific curriculum, Dr Zanetti adds a deep humanistic culture. He is fluent in English, French and Spanish.

17

Board of Directors

Current Position • Director of Division of Epidemiology and Prevention, Maria

Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland

Recent Positions • WHO Consultant • World Bank Consultant • Public Health Advisor to Polish Prime Minister Selection of Honours and Awards • Recipient of several prestigious national and international

awards the World Health Organization and the World Bank, and as a public health advisor to the Polish Prime Minister

Dr Witold Zatonski, Poland Education and Training • MD • One of the leaders in Tobacco Control in Europe, especially active in Eastern Europe • Founder of a successful Tobacco Control Programme in Poland Publications • Author of several publications (Epidemiology, Tobacco Control) Selected UICC Position(s) • 1990’s UICC regional Tobacco Control Coordinator for Eastern and Central Europe Particular Attributes • His tobacco control efforts have had a significant impact in Europe and at UICC, which he has already

served as regional coordinator for tobacco control. He has been especially active in Eastern Europe, where he developed a successful tobacco control programme in Poland. This programme led to total bans on smoking in public places and tobacco advertising, as well as the enlistment of health providers in smoking cessation efforts.

• His tobacco control leadership and invaluable experience will be of immense service to this new governing body. Dr Zatoński is a highly respected leader in the international health community and would be committed to serving UICC’s mission with his time and considerable talent as a board member.

18

Nominating Committee

CRITERIA FOR NOMINATION Nominees should not have, nor appear to have, a conflict of interest that would impair the nominees’ ability to represent objectively the interests of the Nominating Committee. The Nominating Committee as a whole should represent fairly the different sectors of UICC membership (voluntary cancer organisations, treatment centres, patient organisations, research centres, universities as well as those of resource-rich and resource-constrained countries. ELECTION PROCEDURE • The Nominating Committee is composed of the Immediate Past President as Chairman and six other

persons to be elected by the General Assembly, of whom at least two shall be members of the Board of Directors.

• The names of six nominees will be read out and simple majority voting in one block by show of voting cards elects the Nominating Committee. Those with a simple majority are elected.

Green = yes Red = no White = abstention

19

Nominating Committee

Current Position • Director, Oncology Centre Antwerp. Became director of the

Oncology Centre Antwerp (Belgium) in 1998 after an academic career as urological oncologist.

Recent Positions • Past President, European Organisation Research and

Treatment of Cancer • Past Board Member of ESSO and FECS • 1983–1997: Chair, Flemish Advisory Committee for Cancer

prevention • Founding Member, European School of Oncology • Chair International Prostate Health Council

Dr Louis Denis, Belgium Recent Positions (contd) • Founder and Secretary of Europa Uomo, the European coalition of prostate cancer patient support

groups • Founding Manager Director, of European Journal of Cancer • Serves on the Editorial board of a dozen journals • Founding Treasurer, International Consultation on Urological Diseases Education and Training • Finished his urological training at the Medical College of Virginia. Served as Chief Urologist Antwerp

City Hospitals and Professor Urology Vrije Universiteit, Brussels. Selected UICC Positions since 1982 • UICC Treasurer • Member of UICC Council • UICC Executive Committee • Membership, Nominating and Transition Committees (term ends July 2006) • Member of TNM and Prognostic Factors Task Forces • 2000–2002 Interim Secretary-General Particular Attributes • Involved in the development of two diagnostic clinics, four patient support groups (1973–2005), five

professional organisations (1982–2003) and eight professional journals. • Medical background • Has held a great number of medical leadership positions, including in UICC • Thorough understanding of UICC, commitment to current goals, and has personal contact with a

great number of UICC members • Extensive NGO work • Connected to cancer organisations in Europe and throughout the world • Coordinator of a number of randomised trials including the European Randomised Study of Screening

for Prostate Cancer (ERSPC 1994-2006, 261,000 patients).

20

Nominating Committee

Current Position • Danish Cancer Society since 1989, Legal advisor

Recent Positions • 1980-1989: Danish Ministry of Agriculture and Fisheries – EU

related planning, legislation and implementation • 1978-1980: DN Computer Data Elaboration of contracts

International and National Activities • EORTC-European Organisation for Research and Treatment of

Cancer • 1990-1993: Coordinator/secretary to the ECL • 1998 – 2002: Coordinator/secretary to the Nordic Cancer

Union

Ms Elizabeth Hjorth, Denmark Education and Training • LLM, Law degree, University of Copenhagen, Denmark 1978 • Supplementary education and courses: • EU legislation and EU co-operation • Patients’ rights • Personal data protection legislation • Contract law • Intellectual property rights Selected UICC Positions • Cooperation with UICC as a member of ECL • Official UICC contact person of the Danish Cancer Society • UICC Network of Representatives Member contact Particular attributes • Legal background and involvement in EU planning and legislation actions • Understanding of Cancer Society administration and organisation as well as patient support,

research, fundraising and advocacy • In-depth knowledge of cancer societies in Europe, and the network they represent • Carried out work in Denmark in collaboration with research communities • Proven track record of working relations with Nordic Cancer Organisations and European Cancer

Leagues and legal advice on organisational statutory issues, as well as patient support, prevention, public information, research, including commercialisation of research/technology transfer, contracts

21

Nominating Committee

Current Affiliations • Director of the National Cancer Control Programme of the

Ministry of Public Health since August 2005 and in charge of the NCCP programme

• Vice-President of the Steering Committee of the Honorary Committee for the Fight against Cancer

Recent Positions • He developed activities at the Medical School from 1966 to

2004. • For 20 years, he has been Professor and Director of the

Oncology Chair of the Medical School. Dr Ignacio Musé Sevrini, Uruguay Scientific, National and International Activities/Awards • Prepared more than 200 scientific papers • Was awarded seven prizes for scientific papers • Three international scholarships • Founding member of several national and international scientific societies • Member of the publishing committees of several oncology journals • Promoted the development of the cancer information and diffusion centre that covers Uruguay and of

the National Cancer Registry Education and Training • 1968: MD. Medical School, Uruguay • 1974: Assistant Physician. Paris Medical School, France • 1975: Specialist in Internal Medicine. Medical School, Uruguay • 1977: Specialist in Endocrinology. Medical School, Uruguay • 1987: Specialist in Clinical Oncology. School of Medicine, Uruguay Selected UICC Positions • Roll of Honour, February 1997 • Participation in international scientific and educational meetings • Coordinator, Latin American edition of UICC’s Evidence-Based Prevention Handbook • Activities at the Honorary Committee for the Fight against Cancer (Uruguay) • Ideologist and advocate of the law establishing the Institution Particular Attributes • Committed to Cancer Planning and Early Detection, in particular with the UICC Evidence based

publications • Well-recognised and networked with cancer professionals in Latin America • Is linked to community networks in the field of education and cancer control • Promoted the creation and development of the Cancer Information and Diffusion Centre, which

covers the whole country, and of the National Cancer Registry • Has a leadership position in and was a founder of the Honorary Committee for the Fight against

Cancer • Currently in charge of the National Cancer Control Programme of the Ministry of Public Health, which

deals with every aspect of the disease, including rehabilitation and palliative care. • Dr Musé would offer to the Committee his vision and experience in implementing cancer control

policies from the point of view of Latin American and developing countries, and access to networks of cancer professionals in Latin America

22

Nominating Committee

Current Positions • Chairman of the National Advisory Committee on Cancer • Chairman Emeritus, Northern Israel Oncology Center • 1996- Chairman, Israel Cancer Association

Previous Positions • 1958-60 House Physician, Department of Oncology,

Hadassah, University Hospital • 1960-63 Second Assistant, Department of Oncology,

Hadassah, University Hospital • 1965-67 Chief Physician, Department of Oncology,

Hadassah University Hospital • 1968-83 Consultant in Oncology, Northern Israel hospitals • 1968-96 Director, Department of Oncology, Rambam

Medical Center, Haifa

Dr Eliezer Robinson, Israel

Previous Positions contd • 1973-80 Established Investigator, Chief Scientist’s Bureau, Ministry of Health • 1975-96 Chairman, Northern Israel Oncology Center, Ministry of Health and Kupat Holim Education and Training • 1957 MD, Hebrew University, Hadassah Medical School, Jerusalem, Israel • 1961 Department of Clinical Microbiology, Hadassah Medical School, Jerusalem, Israel • 1962 Fellowship at Royal Cancer Hospital, London, England • 1967 Travel Fellowship in Europe and North America from International Agency for Research

on Cancer Academic Positions • 1963-65 Lecturer in Oncology, Hadassah Medical School, Hebrew University • 1967-68 Senior Lecturer in Oncology, Hadassah Medical School, Hebrew University • 1972-78 Associate Professor, Faculty of Medicine, Technion Israel Institute of Technology • Since 1978 Professor, Faculty of Medicine, Technion, Israel Institute of Technology National and International Activities • Israel Medical Association • Israel Radiological Society – until 1990 • Israel Society for Nuclear Medicine – until 1990 • Israel Society for Clinical Oncology and Radiation Oncology • American Society of Clinical Oncology • American Society of Therapeutic Radiology • British Institute of Radiology – until 1985 • European Society of Medical Oncology • European Society of Therapeutic Radiology and Oncology • European Association for Cancer Research • International Association for the Study of Lung Cancer – until 1990 Selected UICC Positions • 2002-2006 Chair of the Nominating Committee • 1998-2002 President • 1994-2006 UICC Council, Executive Committee, Taskforces • 1994-1998 Chairman GLOBAlink • 1998-1995 Cancer Education for Medical Students project/Editor • 1990-1995 Honours and Awards Committee • 1983 ICRETT Fellowship